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Background: Several studies indicate that plasma mem-
brane changes during apoptosis are a general phenome-
non. Among the flow cytometric methods to measure
apoptosis, the Annexin V assay that detects the membrane
exposure of phosphatidylserine (PS) is one of the most
commonly used. However, the various treatments used
for the detachment of adherent cells generally interfere
with the binding of Annexin V to membrane PS, making
apoptosis measurement a technical problem.
Materials and Methods: Apoptosis of different cell lines
was investigated by fluorescence microscopy and multiple
flow assays designed to assess loss of membrane integrity,
translocation of PS, DNA fragmentation, and light scatter
changes.
Results and Conclusions: We show that supravital pro-
pidium iodide (PI) assay stains adherent apoptotic cells,
allowing flow cytometric quantification. Moreover, su-
pravital exposure to PI without prior permeabilization
identifies apoptotic cells as well as Annexin V and permits
the simultaneous surface staining by FITC- and PE-conju-
gated monoclonal antibodies. As in the case of necrotic or
permeabilized cells, fluorescence microscopy has re-
vealed that PI staining of apoptotic cells is localized in the
nucleus. This suggests that the binding of PI to the DNA/
RNA structures is stable enough to withstand the
trypsinization and/or washing procedures necessary to
detach adherent cells. Cytometry 44:57–64, 2001.
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Apoptosis, by counteracting cell proliferation, plays a
fundamental role in the development of tissues and or-
gans, in the regulation of immunological response, and in
the elimination of senescent cells (1–3). The loss of regu-
lation of the apoptotic pathways is often associated with
tumor growth, and radiotherapy and chemotherapy usu-
ally result in apoptotic tumor cell death. Apoptosis can be
induced by chemical and physical agents in tumor and/or
normal cells. Drugs that can produce apoptotic cell death
in tumor cell lines are potentially useful in chemotherapy.
The qualitative and quantitative evaluation of apoptosis
in a cell population has been approached by several tech-
niques. Optical and electronic microscopy, which detects
apoptotic morphological features, was the first method to
be used, and is still used, to verify the presence of apo-
ptotic cells in a sample (2). Gel electrophoresis, which
detects genomic DNA fragmentation, was considered the
hallmark of programmed cell death (1). The technique is
used to qualitatively discriminate between different kinds
of apoptosis (with or without nucleosomal DNA fragmen-
tation). Finally, flow cytometry has allowed the quantita-
tive measurement of apoptotic cells (4–6).
Programmed cell death is usually associated with DNA
fragmentation (1,7–13). However, examples of apoptosis
without DNA fragmentation (14–18) or DNA cleavage
without apoptosis (19) have been described, inducing the
reconsideration of morphological techniques as a golden
standard for the identification of apoptosis. Apoptotic
morphological features observed by microscopy are still
important to define, at least qualitatively, the phenome-
non. Several flow cytometric assays have been developed
to monitor and measure early signs of apoptosis in clinical
trials as well as in basic science studies (4–6,15,20–24).
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Besides the partial loss of cleaved DNA, another important
parameter that flow cytometry evaluates, is cell membrane
alteration. One of the most common flow cytometric
methods utilizes Annexin V to detect early membrane
changes in apoptotic cells (5,6,23,25,26). In previous
studies, we demonstrated that the supravital exposure to
propidium iodide (PI) of unfixed cells in suspension led to
the simultaneous identification of living (PI negative), ap-
optotic (PI dim) and necrotic (PI bright) cells (15,22). In
the present report, we compare this easy flow cytometric
assay, based on supravital exposure to PI, with Annexin V
assay and/or hypodiploid DNA content. Notably, supravi-
tal exposure to PI allows the simultaneous detection of
living, apoptotic, and necrotic cells. It is a reliable assay
even when exposure of phosphatidylserine (PS) residues
does not indicate the presence of apoptosis, as in the case
of adherent cells after detachment (23,26).
MATERIALS AND METHODS
Reagents
Stock solution included 1 mg/ml PI (Calbiochem, La
Jolla, CA) in phosphate-buffered saline (PBS). Annexin
V-FITC was obtained from Clonetech Laboratories (Palo
Alto, CA). Anti-CD7-FITC (Coulter-Immunotech, Marseille,
France), anti-CD71-FITC, and anti-CD3-PE (Becton Dickin-
son, Immunocytometry Systems, San Jose, CA) monoclo-
nal antibodies (mAb) were added contemporaneously
with PI for 30 min at room temperature for the simulta-
neous detection of apoptosis and immunophenotype.
Cell Culture
Jurkat, Raji, and HL-60 human leukemic cell lines were
grown in suspension. SK-N-MC human neuroblastoma
(27) and MCF-7 human breast carcinoma cell lines were
cultured adherent in RPMI 1640 in a 5% CO2 humidified
incubator at 37°C. Cell line cultures were supplemented
with 10% heat-inactivated fetal calf serum (FCS), 2 mM
glutamine, 20 mM Hepes (pH 7.5). For the MCF-7 cell line,
1 mM insulin was also added (Sigma, St. Louis, MO).
Peripheral blood cells from different donors were col-
lected in K3EDTA tubes. Peripheral blood mononuclear
cells (PBMC) from voluntary donors were obtained by
Ficoll-Hypaque gradient centrifugation. PBMC were incu-
bated 30 min at 37°C in plastic Petri dishes to eliminate
adherent cells. Peripheral blood lymphocytes (PBL) and
cell lines were used for apoptosis experiments.
Induction of Apoptosis
Apoptosis was induced by UVB irradiation on PBL, Raji,
HL-60, SK-N-MC, and MCF-7. Cells in 25-ml culture flasks
(1 3 106/ml) were exposed for 20 min to a 302-nm UVB
transilluminator source. They were incubated succes-
sively at 37°C, 5% CO2 for 4 or 7 h. The Jurkat cell line was
treated at 37°C, 5% CO2 for 5 or 6 h with 1 mg/ml of
recombinant tumor necrosis factor (TNF)-related apopto-
sis-inducing ligand (TRAIL; 28).
Detection of Apoptosis
Apoptotic cells were detected by four flow cytometric
methods and by light or fluorescence microscopy.
Flow Cytometry. The flow analysis was performed by
a FACScan or FACStar plus (Becton Dickinson) equipped
with an argon ion laser tuned at 488 nm wavelength. Red,
orange, and green fluorescence intensities were collected
in log scale, whereas forward scatter (FSC) and side scat-
ter (SSC) were collected in linear scale. The emission
filters used were 530 6 30 nm band pass for FITC (FL1),
585 6 42 nm band pass for PE (FL2), and 650 nm long
pass for PI (FL3). Electronic compensation was used to
eliminate bleed through fluorescence. For tricolor analy-
sis, the following settings were used: 560, 450, and 540
mV on photomultiplier tubes for FL1, FL2, and FL3, re-
spectively. Appropriate values of electronic compensation
were adjusted between each fluorochrome: FL1, 0.6%
FL2; FL2, 23.6% FL1; FL2, 38.4% FL3; and FL3, 13.0% FL2.
Data analysis was performed with Lysys II or CellQuest
software (Becton Dickinson).
For supravital PI staining, nonpermeabilized cells were
incubated during the last 30 min in the dark with 50
mg/ml PI. The suspended cell lines were washed with PBS
and then analyzed by flow cytometry (or light microsco-
py). For simultaneous detection of apoptosis and immu-
nophenotype, 2 3 105 cells in 200 ml of PBS were incu-
bated with 50 mg/ml PI and the indicated mAb for 20 min
in the dark at 4 °C. The cells were then washed and
analyzed by flow cytometry. SK-N-MC and MCF-7 adherent
cell lines were incubated during the last 30 min with 50
mg/ml PI. The adherent cells were rinsed twice with PBS
to remove PI and harvested by standard trypsinization (0.5
mg/ml trypsin and 0.2 mg/ml EDTA in PBS; Sigma). De-
tached cells were collected with the supernatants, pel-
leted by centrifugation, and washed with PBS to remove
PI. Detached and adherent cells were finally pooled and
resuspended in PBS before flow cytometric (or light mi-
croscopic) analysis. Apoptotic and necrotic cells were
detected as a PIdim and PIbright cluster, respectively. For
simultaneous detection of apoptosis and immunopheno-
type on adherent cell lines, 2 3 105 adherent cells in 200
ml of PBS were incubated with the indicated mAb for 20
min in the dark at 4°C, washed, and analyzed by flow
cytometry.
For PI staining on ethanol-fixed cells, cells were fixed in
70% cold ethanol for at least 30 min at 4°C. They were
washed in PBS and incubated for 30 min at 37°C with 20
mg/ml PI, 100 mg/ml RNase A type XII (Sigma), 25 mM
Na3citrate, 0.05 M Na2HPO4, and 0.1% Triton X-100, pH
7.8 (citrate buffer). Apoptotic cells were detected on a PI
histogram of ethanol-treated cells as a hypodiploid peak
(20).
For Annexin V staining, cells were washed and resus-
pended in 200 ml of 1 3 binding buffer (Clonetech Lab-
oratories). Staining and analysis were performed following
the manufacturer’s instructions. For simultaneous detec-
tion of supravital PI and Annexin V staining, after induc-
tion of apoptosis, nonpermeabilized cells were incubated
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for 30 min at room temperature in the dark with 50 mg/ml
PI. The cells were then washed with PBS, resuspended in
200 ml of 1 3 binding buffer, and stained with 5 ml of
FITC-Annexin V for 10 min before flow cytometric analy-
sis.
At each experiment, samples were also subjected to
FSC/SSC analysis. It is well known that, due to cell shrink-
age, apoptotic cells generally have decreased FSC. For this
reason, FSC usually represents a gross indicator of mor-
phological changes that occur on cells undergoing apo-
ptosis.
Light/fluorescence microscopy. After apoptosis in-
duction and supravital PI staining (described above), cells
were washed and spun on slides. For microscopic obser-
vations, a Vanox microscope (Olympus Italia, Milan, Italy)
equipped with a mercury lamp was used with a BP545
excitation filter. For viewing both PI-negative viable cells
(which tend to exclude PI) and PI-positive apoptotic cells,
simultaneous application of transmitted light phase-con-
trast and fluorescence microscopy was used.
In some experiments, cells were spun on coverslips,
fixed in cold methanol for 5 min, stained with Giemsa
(Sigma), diluted 1:20 in PBS for 30 min at room tempera-
ture, rinsed twice with PBS, and observed at light micros-
copy.
RESULTS
Detection of Apoptosis by Combined Supravital PI
and Annexin V Assays
The supravital PI staining and Annexin assays detected
similar percentages of apoptosis in Jurkat cells treated for
6 h with 1 mg/ml of TRAIL (Fig.1). To ascertain whether
both techniques identify the same populations, a simulta-
neous detection of apoptosis by supravital PI and Annexin
V assays was performed. Virtually all PI-positive cells were
positive for FITC-Annexin V; moreover, all viable cells,
which excluded PI, were not stained by FITC-Annexin V
(Fig.1, right panel). Similar results were obtained with
UV-treated PBL (not shown). These findings strongly indi-
cate that both techniques identify the same apoptotic
populations.
Simultaneous Detection of Apoptosis and
Immunophenotype
The cultures of Jurkat cells incubated for 5 h with or
without TRAIL (1 mg/ml) were stained with anti-CD7-FITC
mAb and PI as indicated in Materials and Methods. Dot
plots of FITC (X axis) versus PI (Y axis) fluorescence are
represented in Figure 2A (upper panels). Figure 2 shows
that supravital PI staining allows the simultaneous identi-
fication of apoptotic cells and cell surface staining with
FITC-conjugated mAbs. At the same time point, the hyp-
odiploid peak produced by apoptotic cells in ethanol-
fixed samples was also present on treated cells (Fig. 2A,
bottom panels). Furthermore, numerous apoptotic cells
and a few apoptotic fragments were already evident at
light microscopy examination (Fig. 2B). To ascertain the
possibility to perform three-color analysis, PBLs were
stained with anti-CD3-PE mAb and PI (Fig. 2C). As shown
in the Figure 2C, using the appropriate compensation
settings (see Materials and Methods), supravital PI assay
permits the simultaneous surface staining with PE-conju-
gated mAbs. Early apoptosis (PIdim) and cells in secondary
necrosis (PIbright) are also distinguished. Thus, our tech-
nique allows the accurate quantification of apoptotic and
necrotic cells together with their phenotype.
Detection of Apoptosis by Supravital PI Assay on
Adherent Cells
To verify that the supravital PI staining, differently from
Annexin V, could detect apoptosis in adherent cells, PI
was added 30 min before cell harvesting to UV-treated and
untreated SK-N-MC neuroblastoma cells. Before detach-
ment, cells were rinsed with PBS; supernatants and cells
detached after trypsinization were centrifuged and pooled
together. Supravital PI staining detected apoptosis on
these cells after only 4 h of incubation. At this time point,
PIdim apoptotic cells were detectable with high (50 mg/
ml), but not with low (5 mg/ml), PI concentration
(Fig.3A), indicating that a high concentration of PI is
necessary to stain apoptotic cells. Although a clear hypo-
diploid peak was not present yet (not shown), changes in
light scatter characteristics associated with apoptotic trig-
ger were detectable with both PI concentrations in UV-
FIG. 1. Supravital PI and Annexin V assays identify the same apoptotic cells. Jurkat cells were cultured in medium for 6 h with recombinant TRAIL
(1 mg/ml). Cells were separately or simultaneously stained with FITC-Annexin V and PI (see Materials and Methods) and analyzed by flow cytometry.
Percentages of apoptotic cells are indicated. Data are representative of three experiments.
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treated cells (Fig.3A, upper panels and not shown), indi-
cating that apoptosis did not depend on PI concentration.
At 7 h of incubation after UV treatment, comparison
between supravital PI exposure and hypodiploid peak
detected by PI on ethanol-treated cells confirmed that the
supravital PI assay was a reliable and early marker for
detection of apoptosis in adherent cells (Fig. 3B). Changes
in light scatter characteristics detected at 7 h were more
evident than those at 4 h and, surprisingly, were charac-
terized by an increase in FSC (Fig.3B, upper panels). To
confirm that the supravital PI assay worked in combina-
tion with surface antigen detection on different apoptotic
models of adherent cells, SK-N-MC and MCF-7 adherent
cell lines were stained with anti-CD71-FITC mAb and PI.
Figure 3C shows that supravital PI staining allows the
simultaneous identification of apoptotic cells on adherent
cell lines and cell surface staining by FITC-conjugated
mAbs independently on antigen density. In agreement
with previous reports (23,26), but at variance with sus-
pended cells, necrotic (PIbright) cells were not detected in
adherent cells (Fig. 3).
Detection of Apoptosis by Fluorescence
Microscopy
To independently prove that PIdim cells were apoptotic
cells, UV-treated cell lines were analyzed by fluorescence
microscopy after supravital PI exposure. Figure 4 shows
examples of merged images of PI fluorescence and cell
morphology of HL-60, SK-N-MC, and Raji cell lines. Viable
cells are represented by faint peripheral staining gener-
ated by simultaneous application of fluorescence and
transmitted light phase-contrast microscopy. PI labeling of
the nucleus was observed in cells showing typical nuclear
fragmentation and chromatin condensation.
DISCUSSION
Programmed cell death is an active process that leads to
deep nuclear alterations, cytoplasmatic shrinkage, pro-
gressive membrane permeability, and decrease of surface
antigen density (4–6). Ionizing radiation, enzymatic inhib-
itors, growth factor withdrawal, and death receptor trig-
gering are the most common apoptotic stimuli, some of
which are used against tumor cells.
Among the activators of death receptors, we used
TRAIL, a member of the TNF ligand family. Previous data
had suggested that TRAIL selectively killed cancer cells
and it was proposed as an anticancer molecule (29). Nev-
ertheless, it has to be taken into account that our recent
data indicate that it is able to induce a rapid cell death not
only on tumors (28), but also on differentiating cells (30).
Many flow cytometric protocols that target different
cellular compartments have been described to detect ap-
optotic cells. Most of them are focused on the evaluation
of changes of light scatter parameters, indirectly associ-
ated with morphological alterations (4,5,20); low incor-
poration of PI due to the loss of fragmented DNA after
fixation (4,5,31); PI incorporation due to early alterations
of the cell membrane on unfixed cells (6,15,22); and
changes of mitochondrial membrane potential (5,32–34).
FIG. 2. Apoptosis and cell surface phenotype detection by supravital PI
assay. A,B: Jurkat cells were incubated for 5 h with or without TRAIL (1
mg/ml). Cells were labeled with anti-CD7-FITC mAb and PI (A, upper
panels) or they were ethanol fixed and then stained with PI (A, bottom
panels), as indicated in Materials and Methods. Jurkat cells treated for 5 h
with TRAIL were also stained with Giemsa and observed by light micros-
copy (B). Apoptotic fragments and apoptotic cells are indicated by arrows
(3600). C: PBLs were treated for 20 min with UV and control samples
were incubated at 37°C, 5% CO2 for 4 h. Cells were stained with anti-
CD3-PE mAb and PI, as described in Materials and Methods. Percentages
of apoptotic cells are indicated. Data are representative of at least three
experiments.
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In the present study, the apoptosis of different cell lines
was investigated by multiple flow cytometric assays de-
signed to assess the loss of membrane integrity (supravital
PI staining); translocation of PS (Annexin V staining); DNA
fragmentation (PI staining after ethanol treatment); and
light scatter changes (FSC/SSC analysis). Our data confirm
that changes in DNA content, detected by PI incorpora-
tion, and changes in light scatter characteristics, which
are typical of apoptotic cells, appear independently of
each other and usually late during the apoptotic develop-
ment. This seems to be related to the apoptotic model. In
the Jurkat cell line induced to apoptosis by TRAIL, the
hypodiploid peak appears earlier than the scatter modifi-
cations (not shown). The opposite is true in the case of
the neuroblastoma cell line SK-N-MC treated with UV. On
the other hand, supravital PI staining, as well as Annexin
V, recognizes early apoptotic cells. As an example, at 4 h
of incubation after UV treatment of SK-N-MC cells, staining
of apoptotic cells by supravital PI exposure is evident
before the hypodiploid peak appears and when a few
scatter changes are present. The percentages of apoptotic
SK-N-MC cells detected by the hypodiploid peak are re-
producibly lower than those measured by the supravital PI
assay, as expected, but the opposite is true for TRAIL-
treated Jurkat cells. Because membrane alterations are
usually considered an early event if compared with DNA
fragmentation, the percentages of apoptosis based on hy-
podiploid peak should be constantly lower than those
obtained by supravital PI staining. This unexpected result
can be explained by the rapid nuclear fragmentation in-
duced by TRAIL that, after the fixation/permeabilization
procedure (ethanol/citrate buffer), produces fractionation
of single apoptotic cells into multiple apoptotic bodies
(not shown). The presence of nuclear fragments (DNA) in
these apoptotic bodies allows the PI staining, which leads
to an overestimation of the percentage of apoptotic cells.
The higher level of spontaneous cell death detected by PI
staining in the control samples (5.5%) compared with the
FIG. 3. Detection of apoptosis on adherent cells. UV-treated and untreated neuroblastoma adherent cells were incubated for 4 h (A) or 7 h (B). Scatter
plots (A, upper panels, PI 5 mg/ml) and PI fluorescence versus FSC plots of cells stained with 50 mg/ml (A, middle panels) or 5 mg/ml (A, bottom panels)
and percentages of PI-positive cells. Comparison of apoptotic cell percentages detected by supravital PI assay and by PI staining in ethanol-treated cells
is shown in PI fluorescence versus FSC plots (B, upper panels) and PI histograms (B, bottom panels), respectively. UV-treated neuroblastoma (left panels)
and MCF-7 (right panels) adherent cells were incubated for 7 h and then stained with PI and anti-CD71-FITC mAb (C). Data are representative of at least
three experiments.
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supravital PI assay (2.0%; viable cells in culture are usually
evaluated by trypan or PI exclusion) might also suggest
that the overestimation of dead cells is intrinsic of the
fixation/permeabilization procedure necessary for hypo-
diploid peak detection. It is not surprising that the results
obtained with these two approaches do not strictly over-
lap because they measure different attributes of apoptotic
cells and use thresholds to distinguish between apoptosis
and debris that work in different ways.
The evaluation of apoptosis versus necrosis is an impor-
tant parameter to distinguish between efficacy and toxic-
ity of the treatment. Several chemotherapeutic drugs have
been reported to induce apoptosis or necrosis depending
on their concentrations. Therefore, correct evaluation of
apoptosis versus necrosis becomes a fundamental param-
eter to adjust drug dose. Our technique, based on a pro-
gressive increase of the membrane permeability in apo-
ptotic cells, allows the simultaneous detection of
apoptosis and necrosis and has been used in many apo-
ptotic models. This technique successfully examined clas-
sical camptothecin-induced cell death in HL-60 cells, apo-
ptotic P815 cells induced by hyperthermia, apoptosis of
Molt-4 cells in the absence of nucleosomal DNA fragmen-
tation induced by staurosporin (15), tiazofurin-induced
K562 apoptotic cells (35), apoptotic cell death of senes-
cent megakaryocytes (3), and dexamethasone-induced ap-
optotic thymocytes (22). Other groups using different
dyes such as 7-amino-actinomycin D (7-AAD), ethidium
bromide (EB), and Hoeschst 33342 (HO342) found a sim-
ilar progressive impairment of the plasma membrane bar-
rier (24,36–41). Therefore, the data suggest that the in-
crease of membrane permeability to different dyes is a
hallmark of apoptotic cell death.
Annexin V, known to detect membrane alterations of
apoptotic cells that are believed to appear earlier than the
hypodiploid peak and light scatter changes, is widely used
to detect apoptosis. The complete overlapping of Annexin
V-positive cells with the PIdim population demonstrates
that the supravital PI staining technique allows the detec-
tion of apoptosis as early as Annexin V. However, al-
though the Annexin V assay is widely used, it has several
limitations. In fact, PS residues are exposed even in the
absence of apoptosis, for example, in aging erythrocytes
(42), in activated platelets (43–45), or after stimulation of
leukemic cells (46), generating Annexin-positive cells that
prevent their correct quantification of apoptotic cells by
this technique. Moreover, in adherent cells, the evaluation
of apoptosis by Annexin V is not reliable because
trypsinization or scraping induces cell damage and high
numbers of cells staining positive for Annexin V (23,26
and not shown). A fixation step after Annexin V binding
has been proposed to overcome this problem (23,26), but
this assay does not allow the direct discrimination be-
tween apoptotic and necrotic cells. In this assay, the
administration of PI after the detachment of the adherent
cells does not allow discrimination between the apoptotic
cells damaged by detachment procedures and the real
necrotic cells. The high DNA-binding constant and slow
dissociation rate of PI prevent the leakage of PI out of
positive cells. The fact that the PI incorporation by apo-
ptotic and necrotic cells is not a quick reversible phenom-
enon has allowed the introduction in our assay of a wash-
ing step, which is necessary to detect additional specific
FIG. 4. PI staining in UV-treated cell lines was analyzed by fluorescence
microscopy. Apoptotic cells are characterized by nuclear fragmentation
and by strong staining of nuclei due to chromatin condensation. Living
cells exclude PI and faint peripheral staining can be seen by simultaneous
application of transmitted light phase-contrast and fluorescence micros-
copy. UV-treated (A) HL-60 cells (3500), (B) SK-N-MC neuroblastoma cell
line (3660), and (C) Raji cells (31,800) after 7 h of incubation.
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immunofluorescence staining. We found that this washing
step decreased FL2 background and increased discrimina-
tion between viable and apoptotic cells (not shown),
allowing an ideal combination of PI staining with FITC- or
PE-conjugated mAb detection. However, although both
high and low density antigens detected by FITC-conju-
gated mAbs can be easily examined in combination with
PI, the same may not be true for low density antigens
detected by PE-conjugated mAbs. Due to problems of
compensation, PEdim markers may be harder to resolve.
Moreover, trypsin treatment after the PI staining does not
interfere with the detection of apoptotic cells. It is likely
that the membrane packing (47) and/or the transport
function alterations (41) favor the passive diffusion of PI
inside the cell when the dye in the medium is present at
relatively high concentrations (at 50 mg/ml, but not at 5
mg/ml) and for long enough, as previously described (22).
Inside the cell, the PI would bind nuclear structures, as
detected by fluorescence microscopy, strongly enough to
withstand the subsequent washing and trypsinization pro-
cedures. Nevertheless, the mechanical scraping proce-
dure, which damages the plasma membrane, has to be
avoided to impede leakage of PI out of the dead cells into
the damaged ones.
In our experience, most of the cells collected from
supernatants of adherent cells after apoptosis induction
were PIdim, i.e., apoptotic cells. The fact likely reflects the
loss of cell surface antigens and, in particular, of adhesion
molecules, typical of apoptosis (6) and indicates that ap-
optotic cells tend to spontaneously detach from the flask.
In this regard, it becomes important to pool the cells in
suspension with the cells harvested after the detachment
procedures, in order to obtain a correct quantitative anal-
ysis of apoptosis.
This paper describes an assay for measuring apoptosis,
independent of nucleosomal DNA fragmentation (15),
that is extendible to adherent cells. Given the similar
sensitivity, simplicity, and reliability, the supravital PI as-
say might be preferable to Annexin V staining. It is
cheaper and, in contrast to Annexin V-FITC, it works with
adherent cells. Finally, the supravital PI assay is associated
with increased membrane permeability of apoptotic cells.
It allows a quantitative analysis of apoptosis on unfixed
cells, making it possible to evaluate cell surface markers or
to study other features of apoptotic cells such as cytoplas-
mic functions after sorting.
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